Playlist

Turkmenistan Establishes New Regulations for the Trade and Transport of Birds of Prey

05 Apr. 08:06

Source

The Ministry of Environmental Protection of Turkmenistan has officially approved a new set of regulations governing the import, export, purchase, and sale of birds of prey used in traditional falconry. This regulatory framework, enacted in February 2026, aims to organize the activities of falconers and strengthen the conservation of predatory birds such as eagles and falcons. The document was established to implement the national law on hunting and the protection of biological resources.

Under the new rules, all individuals and legal entities owning birds of prey are required to register them with the relevant authorities and the National Society of Falconers of Turkmenistan. The registration process is streamlined to take five business days, resulting in the issuance of an official certificate of ownership. This mandatory registration ensures that all captive birds are documented, supporting both cultural heritage and environmental monitoring.

The international movement of these birds is now strictly controlled through a specialized permit system. Since Turkmenistan joined the CITES Convention, additional international permits are required for species listed as endangered. Any attempt to bring birds into the country or take them abroad without these documents is strictly prohibited. This measure aligns Turkmenistan's domestic policies with international wildlife trade standards, preventing the illegal trafficking of rare species.

The regulations also clarify the legal procedures for changing ownership through sales, exchanges, or gifts. Owners must notify the authorized agencies of any such transactions to ensure the state registry remains accurate. By establishing these comprehensive rules, Turkmenistan aims to protect its ancient falconry traditions while ensuring that the exploitation of birds of prey remains sustainable and legally transparent.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌